J&J makes takeover approach for Swiss drugmaker Actelion: Report

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 24 November, 2016 by The TZ Newswire Staff

J&J makes takeover approach for Swiss drugmaker Actelion: Report

U.S. health care company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday.

See also
- Next Article Option expiries for the 10 am NY cut today 25 Nov
- Previous Article Exclusive: Anet Azrielant Joins FXGlobe as Chief Operating Officer
Editorial Calender

November 2016

M T W T F S S

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30

« Oct Dec »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 24 November, 2016 by The TZ Newswire Staff

J&J makes takeover approach for Swiss drugmaker Actelion: Report

See also

Editorial Calender

Recent Tags